Strides Pharma teams up with Ennaid Therapeutics to manufacture COVID-19 drug
Strides Pharma teams up with Ennaid Therapeutics to manufacture COVID-19 drug
15 June 2021 | News Ennaid Therapeutics will produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19
Image Credit: shutterstock.com
Bengaluru-based Strides Pharma Science has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has entered into an exclusive partnership with US-based Ennaid Therapeutics, a global pharmaceutical company to produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19.
Ennaid’s partnership with discovery scientists at Universidad Católica de Murcia (UCAM), identified a therapeutic target to treat COVID‐19 using artificial intelligence drug discovery platforms.
Stocks in Focus on June 15: Coal India, Shyam Metalics, JSW Ispat, Clariant Chemicals to Pharma Stocks; here are the 5 Newsmakers of the Day
zeebiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zeebiz.com Daily Mail and Mail on Sunday newspapers.
Stocks To Watch In Trade In Today s Session (June 15, 2021): Coal India, Strides Pharma Science, NHPC, Jaiprakash Power Ventures
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
BPCL share price: Stocks in the news: BPCL, Strides Pharma, Coal India, JB Chemicals and Jubilant FoodWorks
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.